stockrowCastle Biosciences, Inc. (CSTL) vs Myriad Genetics, Inc. (MYGN)
- Castle Biosciences, Inc. CSTL 32.08 −6.20%
- Myriad Genetics, Inc. MYGN 6.07 −3.50%
Castle Biosciences, Inc. and Myriad Genetics, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $601.6M — 1.7× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 9.78% against −3.16%. Castle Biosciences, Inc. has the higher net margin (−6.10% vs −14.0%) and the higher return on invested capital (−3.63% vs −19.9%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 13 and Myriad Genetics, Inc. on 5.
Valuation
Profitability
| Metric | CSTL | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.07% | 68.83% | 48.32% |
| Operating margin | (7.43%) | (12.22%) | (5.68%) |
| Net margin | (6.10%) | (13.96%) | (4.10%) |
| Free cash flow margin | 1.06% | (1.76%) | 0.00% |
| Return on equity | (4.87%) | (32.54%) | 0.00% |
| Return on assets | (4.03%) | (17.11%) | (6.05%) |
| Return on invested capital | (3.63%) | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack